These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 7559193
1. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii. Romand S, Bryskier A, Moutot M, Derouin F. J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193 [Abstract] [Full Text] [Related]
2. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Romand S, Pudney M, Derouin F. Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620 [Abstract] [Full Text] [Related]
3. In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii. Romand S, Della Bruna C, Farinotti R, Derouin F. Antimicrob Agents Chemother; 1996 Sep; 40(9):2015-20. PubMed ID: 8878573 [Abstract] [Full Text] [Related]
4. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model. Martins-Duarte ÉS, de Souza W, Vommaro RC. Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807 [Abstract] [Full Text] [Related]
5. In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice. Piketty C, Derouin F, Rouveix B, Pocidalo JJ. Antimicrob Agents Chemother; 1990 Aug; 34(8):1467-72. PubMed ID: 2221854 [Abstract] [Full Text] [Related]
6. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model. Brun-Pascaud M, Chau F, Derouin F, Girard PM. J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714 [Abstract] [Full Text] [Related]
7. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis. Derouin F, Almadany R, Chau F, Rouveix B, Pocidalo JJ. Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642 [Abstract] [Full Text] [Related]
12. In vivo activity of piritrexim [corrected] against Toxoplasma gondii. Araujo FG, Guptill DR, Remington JS. J Infect Dis; 1987 Nov; 156(5):828-30. PubMed ID: 3484324 [No Abstract] [Full Text] [Related]
13. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations. Seah SK. J Trop Med Hyg; 1975 Jul; 78(7):150-3. PubMed ID: 1177347 [Abstract] [Full Text] [Related]
14. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice. Nguyen BT, Stadtsbaeder S. Br J Pharmacol; 1983 Aug; 79(4):923-8. PubMed ID: 6606459 [Abstract] [Full Text] [Related]
15. Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis. Derouin F, Gérard L, Farinotti R, Maslo C, Leport C. J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep 01; 19(1):50-4. PubMed ID: 9732069 [Abstract] [Full Text] [Related]
16. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models. Barbosa BF, Gomes AO, Ferro EA, Napolitano DR, Mineo JR, Silva NM. Vet Parasitol; 2012 Jun 08; 187(1-2):44-52. PubMed ID: 22281151 [Abstract] [Full Text] [Related]